CUAMC
KZR

China Universal Asset Management Company’s Kezar Life Sciences KZR Stock Holding History

China Universal Asset Management Company’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-186
Closed -$2.21K – 461
2023
Q3 		$2.21K Buy
186
+91
+96% +$1.61K ﹤0.01% 429
2023
Q2 		$2.33K Buy
95
+2
+2% +$52 ﹤0.01% 420
2023
Q1 		$2.9K Buy
93
+23
+33% +$1.33K ﹤0.01% 415
2022
Q4 		$4.89K Buy
70
+6
+9% +$445 ﹤0.01% 301
2022
Q3 		$6K Buy
+64
New +$6.22K ﹤0.01% 255

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

China Universal Asset Management Company's KZR Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Kezar Life Sciences (KZR) in Q4 2023, closing a stake of 186 shares — an estimated $2.21K sold.

China Universal Asset Management Company first reported a position in KZR in Q3 2022 and held it in 5 quarters. The position peaked at $6K in Q3 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q4 2023.

  • China Universal Asset Management Company reported no remaining Kezar Life Sciences position as of Q4 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 186 Kezar Life Sciences shares in Q4 2023, an estimated $2.21K.
  • China Universal Asset Management Company first reported a position in Kezar Life Sciences in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's Kezar Life Sciences position peaked at $6K in Q3 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.